EZM 2302
CAS: 1628830-21-6
Ref. 3D-DQC83021
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
EZM 2302
Description:
EZM 2302 is a histone deacetylase (HDAC) inhibitor that inhibits the activity of HDACs, which are enzymes that regulate gene transcription. EZM 2302 has been shown to inhibit the growth of leukemia cells in vitro and in vivo. It has also been shown to inhibit tumorigenesis by halting oncogenic signaling pathways and inducing cell death. EZM 2302 has also been found to be a methyltransferase inhibitor, inhibiting the activity of methyltransferases. This inhibition prevents the production of proteins necessary for cancer development.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
585.09 g/mol
Formula:
C29H37ClN6O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
